Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.29 1.19 0.81 1.02
P/FCF ratio
16.25 15.76 12.07 14.72
P/Operating CF
41.02 51.08 90.25 37.57
P/B ratio
1.53 1.40 0.95 1.19
EV/Sales
1.84 1.74 1.35 1.54
EV/EBITDA
17.75 65.97 68.22 80.81
EV/FCF
23.14 22.99 20.13 22.18
Current Ratio
1.49 1.78 1.76 1.78
Net Debt/EBITDA
(6.65) 15.46 17.14 14.80
Debt/Equity
0.69 0.71 0.68 0.66
Earnings Yield
(0.96%) (6.81%) (10.33%) (8.48%)
Free Cash Flow Yield
6.15% 6.35% 8.29% 6.79%
Free Cash Flow per Share
0.25 0.17 0.04 0.21
Book value per Share
8.17 8.18 8.27 8.33
Free Cash Flow
171.70 117.20 25.20 140.60
EV/EBIT
45.63 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates